| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/24/1998 | EP0848712A1 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 06/24/1998 | EP0848615A1 Multi-subtype fiv vaccines |
| 06/24/1998 | EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 06/24/1998 | EP0680468B1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
| 06/24/1998 | CN1185810A Synthetic HPV6/11 hybrid L1 DNA encoding human papliomavirus type 11 L1 protein |
| 06/24/1998 | CN1185806A New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), vaccines and diagnostic means obtainable with said strain, and production process |
| 06/24/1998 | CN1185783A Esters of carbapenems |
| 06/24/1998 | CN1185739A Cyclic peptide antifungal agents |
| 06/24/1998 | CN1185737A Isothiazolones |
| 06/24/1998 | CN1038841C Polypeptide and anti-hiv agent prepared therefrom |
| 06/23/1998 | US5770719 Isolated nucleic acid containing promoter sequence from a gene which codes for an adenosine triphosphatase |
| 06/23/1998 | US5770703 Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene |
| 06/23/1998 | US5770689 Hepatitis E virus ORF Z peptides |
| 06/23/1998 | US5770617 Terbenzimidazoles useful as antifungal agents |
| 06/23/1998 | US5770607 Aqueous liquid composition for external use |
| 06/23/1998 | US5770597 Antibiotic |
| 06/23/1998 | US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 06/23/1998 | US5770579 Erythromycin compounds |
| 06/23/1998 | US5770578 Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments |
| 06/23/1998 | US5770569 Diagnostic and therapeutic agents using a lymphocyte adhesion receptor for high endothelium CD44 |
| 06/23/1998 | US5770427 Retrovirus from the HIV group and its use |
| 06/23/1998 | US5770361 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 06/23/1998 | US5770213 Endotoxin-free; otitis media, sinusitis, meningitis, and chronic pulmonary obstructive disease |
| 06/23/1998 | US5770211 Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| 06/23/1998 | US5770208 Staphylococcus aureus B-linked hexosamine antigen |
| 06/23/1998 | US5770203 Modified cholera toxin based on mutagenized subunit A |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | CA2176506C Substituted oxindoles |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/23/1998 | CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 06/23/1998 | CA2079887C Purification of a pertussis outer membrane protein |
| 06/20/1998 | CA2202322A1 Conserved metalloprotease epitopes |
| 06/18/1998 | WO1998026077A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE β AS MEDICINE |
| 06/18/1998 | WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025961A1 Antimicrobially active polypeptides |
| 06/18/1998 | WO1998025942A1 Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 06/18/1998 | WO1998025935A1 Novel cephem derivatives |
| 06/18/1998 | WO1998025925A1 Pyrrole derivatives, their preparation and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | WO1998025638A1 Use of plant extract for inhibition of haemophilus influenzae |
| 06/18/1998 | WO1998025599A1 An oil composition of dihydropolyprenols |
| 06/18/1998 | WO1998025593A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kB FACTOR |
| 06/18/1998 | WO1998025471A1 A method of biological control |
| 06/18/1998 | WO1998025470A1 A method of biological control |
| 06/18/1998 | WO1998018477A3 Pharmaceutical compositions containing lamivudine and zidovudine |
| 06/18/1998 | WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them |
| 06/18/1998 | DE19652239A1 Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -chinolon- -naphthyridoncarbonsäure and derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith |
| 06/18/1998 | DE19652219A1 Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (1-Aminomethyl-2-oxa-7-azabicyclo [3.3.0] oct-7-yl) -chinolon- and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith |
| 06/18/1998 | CA2276094A1 Antimicrobially active polypeptides |
| 06/18/1998 | CA2275340A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | CA2274900A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene |
| 06/18/1998 | CA2274797A1 Novel cephem derivatives |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2269680A1 An oil composition of dihydropolyprenols |
| 06/17/1998 | EP0848064A1 New antibiotic, Feglymycine, process for its preparation and use of the same |
| 06/17/1998 | EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy |
| 06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
| 06/17/1998 | EP0848060A2 Novel human 11CB splice variant |
| 06/17/1998 | EP0847756A1 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis |
| 06/17/1998 | EP0847400A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin |
| 06/17/1998 | EP0847397A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 06/17/1998 | EP0789697B1 CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| 06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
| 06/17/1998 | CN1185158A Prepn. of clavulanate salts |
| 06/17/1998 | CN1185115A 多粘菌素轭合物 Polymyxin conjugates |
| 06/17/1998 | CN1185111A Eipthelial adhesive lactobacilli |
| 06/17/1998 | CN1185110A Synergistic combination of zidovudine |
| 06/17/1998 | CN1184815A Cephalosporin pyridinium derinvatives |
| 06/17/1998 | CN1184674A Pseudomonas active protein and method for producing same |
| 06/17/1998 | CN1184662A Powder for removing toxic substances and promoting granulation |
| 06/17/1998 | CN1038728C IBDV prodn. in continuous lines |
| 06/16/1998 | US5767250 Complexes comprising truncated CMV gH polypeptides and escort proteins |
| 06/16/1998 | US5767240 Activity-dependent neurotrophic factor |
| 06/16/1998 | US5767140 5,5-Disubstituted hydantoins |
| 06/16/1998 | US5767127 Optically active pyridonecarboxylic acid derivatives |
| 06/16/1998 | US5767122 Enantiomerically pure β-d-dioxolane nucleosides |
| 06/16/1998 | US5767120 Antiinflammatory agents, antiallergens; treatment for septic shock |
| 06/16/1998 | US5767096 Produced by culturing dactylosporangium in a bromide enriched nutrient medium |
| 06/16/1998 | US5767085 Peptide derivatives |
| 06/16/1998 | US5767069 Cyclosporins |
| 06/16/1998 | US5766892 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
| 06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
| 06/16/1998 | US5766624 Liposomal defensins |
| 06/16/1998 | US5766619 Pharmaceutical dosage form for ocular administration and preparation process |
| 06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
| 06/16/1998 | US5766601 Cross-reactive influenza a immunization |
| 06/16/1998 | US5766599 Attenuated virus; genetic engineering |
| 06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
| 06/16/1998 | CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 06/16/1998 | CA2132457C Fluorosugar derivatives of macrolides |
| 06/16/1998 | CA2040374C Process for enhancing the resistance of aquatic animals to disease |